Life Science Strategy

Our Life Science Strategy: A Sharpened Focus to Drive Transformation

Over the past decade, our Life Science business has emerged as a top global player serving academia, the biopharmaceutical industry, and the industrial sector. Our purpose is to impact life and health with science.

To fulfill this aspiration, deliver our ambitious growth plans and meet the needs of our customers in an evolving and dynamic market, we will focus on capitalizing on the key trends, including:

• Focus on network and capacity expansions in-region, for-region. Continue to invest in new capacity for key portfolios in our bioprocessing business, including single-use, filtration, and cell culture media. 
• Unite our top-tier positions across diverse lab and testing segments, enabling us to remain a leading player in the academic and government scientific communities with continued product innovation, including digital features, greener alternatives, and omnichannel engagement.
• Provide service offerings that continue leadership in the attractive and growing contract testing, development, and manufacturing organization (CTDMO) segment. With more than 25 years of CDMO expertise, a global footprint, and capabilities across the value chain, we are positioned to realize our vision to be a leading, full-service, focused, multi-modality CTDMO. 
• Perform innovation, digitalization, and resource allocation, expanding globally in key regions, including China. 
  

Our Life Science Strategy: A Sharpened Focus to Drive Transformation

Over the past decade, the Life Science business of Merck KGaA, Darmstadt, Germany, has emerged as a top global player serving academia, the biopharmaceutical industry, and the industrial sector. Our purpose is to impact life and health with science. To fulfill this aspiration, deliver our ambitious growth plans and meet the needs of our customers in an evolving and dynamic market, we will focus on capitalizing on the key trends, including:

• Focus on network and capacity expansions in-region, for-region. Continue to invest in new capacity for key portfolios in our bioprocessing business, including single-use, filtration, and cell culture media.
• Unite our top-tier positions across diverse lab and testing segments, enabling us to remain a leading player in the academic and government scientific communities with continued product innovation, including digital features, greener alternatives, and omnichannel engagement.
• Provide service offerings that continue leadership in the attractive and growing contract testing, development, and manufacturing organization (CTDMO) segment. With more than 25 years of CDMO expertise, a global footprint, and capabilities across the value chain, we are positioned to realize our vision to be a leading, full-service, focused, multi-modality CTDMO.
• Perform innovation, digitalization, and resource allocation, expanding globally in key regions, including China.